Dimethyl fumarate Mylan Europese Unie - Nederlands - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Europese Unie - Nederlands - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Europese Unie - Nederlands - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimethylfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Europese Unie - Nederlands - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimethylfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Neuraxpharm Europese Unie - Nederlands - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethylfumaraat Teva 120 mg, harde maagsapresistente capsules Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

dimethylfumaraat teva 120 mg, harde maagsapresistente capsules

dimethylfumaraat 120 mg/stuk - maagsapresistente capsule, hard - ammonia (e 527) ; briljantblauw fcf (e 133) ; cellulose, microkristallijn (e 460(i)) ; copolymeer van ethylacrylaat-methacrylzuur (1:1) ; crospovidon (e 1202) ; gelatine (e 441) ; glyceroltriacetaat (e 1518) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; magnesiumstearaat (e 470b) ; povidon k 30 (e 1201) ; propyleenglycol (e 1520) ; schellak (e 904) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505) ; zwarte inkt, ammonia (e 527) ; briljantblauw fcf (e 133) ; cellulose, microkristallijn (e 460) ; copolymeer van ethylacrylaat-methacrylzuur (1:1) ; crospovidon (e 1202) ; gelatine (e 441) ; glyceroltriacetaat (e 1518) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; magnesiumstearaat (e 470b) ; povidon k 30 (e 1201) ; propyleenglycol (e 1520) ; schellak (e 904) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505) ; zwarte inkt

Dimethylfumaraat 1A Pharma 120 mg, harde maagsapresistente capsules Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

dimethylfumaraat 1a pharma 120 mg, harde maagsapresistente capsules

dimethylfumaraat 120 mg/stuk - maagsapresistente capsule, hard - ammonia (e 527) ; briljantblauw fcf (e 133) ; copolymeer van ethylacrylaat-methacrylzuur (1:1) ; copolymeer van methacrylzuur-methylmethacrylaat (1:1) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; glycerolmonostearaat 40-55 (e 471) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; natriumstearylfumaraat ; polysorbaat 80 (e 433) ; propyleenglycol (e 1520) ; schellak glaze, gedeeltelijk veresterd ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505) ; zwarte inkt

Dimethylfumaraat 1A Pharma 240 mg, harde maagsapresistente capsules Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

dimethylfumaraat 1a pharma 240 mg, harde maagsapresistente capsules

dimethylfumaraat 240 mg/stuk - maagsapresistente capsule, hard - ammonia (e 527) ; briljantblauw fcf (e 133) ; copolymeer van ethylacrylaat-methacrylzuur (1:1) ; copolymeer van methacrylzuur-methylmethacrylaat (1:1) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; glycerolmonostearaat 40-55 (e 471) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; natriumstearylfumaraat ; polysorbaat 80 (e 433) ; propyleenglycol (e 1520) ; schellak glaze, gedeeltelijk veresterd ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505) ; zwarte inkt